Intersection of biobanking and clinical care: Should discrepant diagnoses and pathological findings be returned to research participants?

Nicole C. Lockhart, Rihab Yassin, Carol J. Weil, Carolyn Compton

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Diagnostic discrepancies occur when the diagnosis made on a biospecimen during the course of review at a biobank differs from the original clinical diagnosis. These diagnostic discrepancies detected during biobanking present unique challenges that are distinct from other types of research results or incidental findings. The proposed process for reporting diagnostic discrepancies or pathological incidental findings identified through a quality assurance evaluation at the biobank includes verification of the biospecimen identity, verification of the diagnosis within the biobank, and re-review of the case by the pathologist at the biospecimen collection site. If the pathologist at the biobank and the original pathologist do not reach agreement, an impartial and knowledgeable third party is consulted. The decision as to whether and how to notify research participants of any confirmed changes in diagnosis would be determined by institutional procedures. Implementation of this proposed process will require clear delineation of the roles and responsibilities of all involved parties in order to promote excellence in patient care and ensure that researchers have access to biospecimens of requisite quality.

Original languageEnglish (US)
Pages (from-to)417-423
Number of pages7
JournalGenetics in Medicine
Volume14
Issue number4
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Incidental Findings
Research
Patient Care
Research Personnel
Pathologists

Keywords

  • biobank
  • biospecimen
  • diagnostic discrepancy
  • incidental finding
  • return of research results

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Intersection of biobanking and clinical care : Should discrepant diagnoses and pathological findings be returned to research participants? / Lockhart, Nicole C.; Yassin, Rihab; Weil, Carol J.; Compton, Carolyn.

In: Genetics in Medicine, Vol. 14, No. 4, 04.2012, p. 417-423.

Research output: Contribution to journalArticle

@article{d89e41c733e24be3aa13afc38693104f,
title = "Intersection of biobanking and clinical care: Should discrepant diagnoses and pathological findings be returned to research participants?",
abstract = "Diagnostic discrepancies occur when the diagnosis made on a biospecimen during the course of review at a biobank differs from the original clinical diagnosis. These diagnostic discrepancies detected during biobanking present unique challenges that are distinct from other types of research results or incidental findings. The proposed process for reporting diagnostic discrepancies or pathological incidental findings identified through a quality assurance evaluation at the biobank includes verification of the biospecimen identity, verification of the diagnosis within the biobank, and re-review of the case by the pathologist at the biospecimen collection site. If the pathologist at the biobank and the original pathologist do not reach agreement, an impartial and knowledgeable third party is consulted. The decision as to whether and how to notify research participants of any confirmed changes in diagnosis would be determined by institutional procedures. Implementation of this proposed process will require clear delineation of the roles and responsibilities of all involved parties in order to promote excellence in patient care and ensure that researchers have access to biospecimens of requisite quality.",
keywords = "biobank, biospecimen, diagnostic discrepancy, incidental finding, return of research results",
author = "Lockhart, {Nicole C.} and Rihab Yassin and Weil, {Carol J.} and Carolyn Compton",
year = "2012",
month = "4",
doi = "10.1038/gim.2012.11",
language = "English (US)",
volume = "14",
pages = "417--423",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Intersection of biobanking and clinical care

T2 - Should discrepant diagnoses and pathological findings be returned to research participants?

AU - Lockhart, Nicole C.

AU - Yassin, Rihab

AU - Weil, Carol J.

AU - Compton, Carolyn

PY - 2012/4

Y1 - 2012/4

N2 - Diagnostic discrepancies occur when the diagnosis made on a biospecimen during the course of review at a biobank differs from the original clinical diagnosis. These diagnostic discrepancies detected during biobanking present unique challenges that are distinct from other types of research results or incidental findings. The proposed process for reporting diagnostic discrepancies or pathological incidental findings identified through a quality assurance evaluation at the biobank includes verification of the biospecimen identity, verification of the diagnosis within the biobank, and re-review of the case by the pathologist at the biospecimen collection site. If the pathologist at the biobank and the original pathologist do not reach agreement, an impartial and knowledgeable third party is consulted. The decision as to whether and how to notify research participants of any confirmed changes in diagnosis would be determined by institutional procedures. Implementation of this proposed process will require clear delineation of the roles and responsibilities of all involved parties in order to promote excellence in patient care and ensure that researchers have access to biospecimens of requisite quality.

AB - Diagnostic discrepancies occur when the diagnosis made on a biospecimen during the course of review at a biobank differs from the original clinical diagnosis. These diagnostic discrepancies detected during biobanking present unique challenges that are distinct from other types of research results or incidental findings. The proposed process for reporting diagnostic discrepancies or pathological incidental findings identified through a quality assurance evaluation at the biobank includes verification of the biospecimen identity, verification of the diagnosis within the biobank, and re-review of the case by the pathologist at the biospecimen collection site. If the pathologist at the biobank and the original pathologist do not reach agreement, an impartial and knowledgeable third party is consulted. The decision as to whether and how to notify research participants of any confirmed changes in diagnosis would be determined by institutional procedures. Implementation of this proposed process will require clear delineation of the roles and responsibilities of all involved parties in order to promote excellence in patient care and ensure that researchers have access to biospecimens of requisite quality.

KW - biobank

KW - biospecimen

KW - diagnostic discrepancy

KW - incidental finding

KW - return of research results

UR - http://www.scopus.com/inward/record.url?scp=84859561551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859561551&partnerID=8YFLogxK

U2 - 10.1038/gim.2012.11

DO - 10.1038/gim.2012.11

M3 - Article

C2 - 22344228

AN - SCOPUS:84859561551

VL - 14

SP - 417

EP - 423

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 4

ER -